(Q46645570)

23 December 2017

title

Long-term use and tolerability of cyclooxygenase-2 inhibitors in patients with analgesic intolerance (English)

1 reference

23 December 2017

author name string

Gülfem Celik

1

1 reference

23 December 2017

Ferda Oner Erkekol

2

1 reference

23 December 2017

Sevim Bavbek

3

1 reference

23 December 2017

Berna Dursun

4

1 reference

23 December 2017

Zeynep Misirligil

5

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

Annals of Allergy, Asthma & Immunology

published in

1 reference

23 December 2017

volume

95

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

33-37

1 reference

23 December 2017

Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Aspirin intolerance and the cyclooxygenase-leukotriene pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

1 reference

7 January 2021

The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

The safety of celecoxib in patients with aspirin-sensitive asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Long-term tolerability of nimesulide and acetaminophen in nonsteroidal antiinflammatory drug-intolerant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

Adverse nondrug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961185-4

7 January 2021

10.1016/S1081-1206(10)61185-4

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

16095139

1 reference

23 December 2017